Swedish Orphan Biovitrum AB (publ)

OM:SOBI Stock Report

Market Cap: kr96.3b

Swedish Orphan Biovitrum AB (publ) Company Information

Swedish Orphan Biovitrum AB (publ)'s employee growth, exchange listings and data sources


Key Information

  • Name: Swedish Orphan Biovitrum AB (publ)
  • Ticker: SOBI
  • Exchange: OM
  • Founded: 1939
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: kr96.319b
  • Shares Outstanding: 339.87m
  • Website: https://www.sobi.com

Number of Employees


Location

  • Swedish Orphan Biovitrum AB (publ)
  • Tomtebodavägen 23A
  • Solna
  • Stockholm County
  • 112 76
  • Sweden


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SOBIOM (OMX Nordic Exchange Stockholm)YesClass A SharesSESEKSep 2006
B6EDB (Deutsche Boerse AG)YesClass A SharesDEEURSep 2006
0MTDLSE (London Stock Exchange)YesClass A SharesGBSEKSep 2006
BIOV.FOTCPK (Pink Sheets LLC)YesClass A SharesUSUSDSep 2006
SOBISBATS-CHIXE (BATS 'Chi-X Europe')YesClass A SharesGBSEKSep 2006
SOBI NBMV (Bolsa Mexicana de Valores)YesClass A SharesMXMXNSep 2006
SWOB.YOTCPK (Pink Sheets LLC)UNSPON ADS EACH REP 0.5 ORD SHSUSUSDApr 2023
B6E0DB (Deutsche Boerse AG)UNSPON ADS EACH REP 0.5 ORD SHSDEEURApr 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/04/29 00:00
End of Day Share Price 2024/04/29 00:00
Earnings2024/03/31
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.